Intraductal papillary mucinous neoplasms: Does a family history of pancreatic cancer matter?

Pancreatology

Volumn 12, Issue 4, 2012, Pages 358-363

  Nehra, Deepika ^a   Oyarvide, Vicente Morales ^a   Mino Kenudson, Mari ^a   Thayer, Sarah P ^a   Ferrone, Cristina R ^a   Wargo, Jennifer A ^a   Muzikansky, Alona ^a   Finkelstein, Dianne ^a   Warshawa, Andrew L ^a   Castillo, Carlos Fernández Del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Family history; Intraductal papillary mucinous neoplasm; Pancreatic cancer

Indexed keywords

AGED; ARTICLE; ATTRIBUTABLE RISK; CANCER INVASION; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; FAMILY HISTORY; FEMALE; GENERAL HOSPITAL; HEREDITY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME;

EID: 84866494735     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.05.011     Document Type: Article

References (21)

1. Augustin T, Vandermeer TJ. Intraductal papillary mucinous neoplasm: a clinicopathologic review. The Surgical Clinics of North America 2010;90:377-98.
2. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81. quiz 665. (Pubitemid 43825802)
3. Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 2009;15:7737-43.
4. Kloppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological typing of tumors of the exocrine pancreas. World health organization international classification of tumors. Berlin: Springer; 1996. pp. 11-20.
5. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Research 2004;64:2634-8. (Pubitemid 38523922)
6. Bartsch DK. Familial pancreatic cancer. Br J Surg 2003;90:386-7. (Pubitemid 36458099)
7. Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, et al. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 2002;97:807-10. (Pubitemid 34106336)
8. Lynch HT, Fitzsimmons ML, Smyrk TC, Lanspa SJ, Watson P, McClellan J, et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. The American Journal of Gastroenterology 1990;85:54-60. (Pubitemid 20038980)
9. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 2006;4:766-81. quiz 665. (Pubitemid 43825802)
10. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21. (Pubitemid 38834045)
11. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. The American Journal of Gastroenterology 2009;104:2175-81.
12. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Annals of Surgery 2004;239:788-97 [discussion 797-789].
13. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Medicine 2004;1:e65.
14. Choi MG, Kim SW, Han SS, Jang JY, Park YH. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg 2006;141:51-6 [discussion 56].
15. Eguchi H, Ishikawa O, Ohigashi H, Tomimaru Y, Sasaki Y, Yamada T, et al. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery 2006;139:749-54. (Pubitemid 43902908)
16. Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005;11:5688-90. (Pubitemid 41684925)
17. Riall TS, Stager VM, Nealon WH, Townsend Jr CM, Kuo YF, Goodwin JS, et al. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg 2007;204:803-13 [discussion 813-804]. (Pubitemid 46661192)
18. Gill KR, Scimeca D, Stauffer J, Krishna M, Woodward TA, Jamil LH, et al. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence? JOP 2009;10: 515-7.
19. Goh BK, Tan YM, Yap WM, Cheow PC, Chow PK, Chung YF, et al. Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms. World J Surg 2006;30:1553-9. (Pubitemid 44421261)
20. Ishida M, Egawa S, Kawaguchi K, Aoki T, Sakata N, Mikami Y, et al. Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas. Pancreatology: Official Journal of the International Association of Pancreatology 2008;8: 577-82.
21. Larghi A, Stobinski M, Galasso D, Lecca PG, Costamagna G. Concomitant intraductal papillary mucinous neoplasm and pancreatic endocrine tumour: report of two cases and review of the literature. Dig Liver Dis 2009;41: 759-61.